Global Blood Therapeutics (GBT) will ask the U.S. Food and Drug Administration (FDA) to allow children with sickle cell disease (SCD),…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Forma Therapeutics‘ FT-4202 for the…
Children and adolescents with sickle cell disease (SCD) who lack vitamin D are hospitalized more often due to…
The American Society of Hematology released new clinical guidelines on the use of blood transfusions in people with…
Voxelotor can reduce the severity of existing leg ulcers and the incidence of new ones in people with sickle cell…
Children with sickle cell disease (SCD) who arrive at an emergency department with vaso-occlusive episodes (VOEs) are more likely to…
A new way to monitor blood cells that doesn’t require microscopic imaging or biochemical markers may allow for better management…
Global Blood Therapeutics (GBT) announced the five organizations that will receive more than $200,000 worth of grants through its…